ERVIMMUNE

Pharmaceutical preparations for the treatment of cancer; therapeutic vaccines; Medical preparations, namely, T-cell therapy preparations for the treatment of cancer; stem cells for medical use; biological preparations for the prevention and treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the prevention and treatment of cancer; chemical preparations for medical purposes, namely, for the prevention or treatment of cancer; medicinal preparations for the treatment of infectious diseases and for use in immunotherapy and oncology; all aforementioned goods not for use in the field of medical diagnostics

Medical research laboratory services; biotechnological and pharmaceutical drug research and development services; pharmaceutical and biotechnological research and development; provision of medical and scientific research information in the field of pharmaceuticals; provision of medical and scientific research information in the field of therapeutic vaccines; provision of medical and scientific research information in the field of oncology, immunotherapy, stem cell therapy, and T-cell therapy; Providing medical and scientific research information in the field of clinical trials; screening and selection of molecules for scientific and pharmacological research purposes, not for medical purposes; research and development in the field of immunotherapy; all aforementioned services not for use in the field of medical diagnostics

Medical and surgical services in the field of immunotherapy and oncology; medical testing for treatment purposes; provision of medical information in the field of immunotherapy and oncology; medical analysis for the treatment of persons; genetic testing services for medical purposes; all aforementioned services not for use in the field of medical diagnostics